Microchips in Medicine Market Analysis

  • Report ID: 3734
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Microchips in Medicine Market Segmentation:

Application (Drug Administration, Home Monitoring)

The drug administration segment is estimated to hold 55% share of the microchips in medicine market in the coming years owing to the increasing demand for smart drug delivery systems, which are driven by growing awareness about the benefits of using microchips in drug delivery systems. Extreme flexibility in drug delivery is made possible by microchip technology, which consists of drug-filled sockets that release the medicine at predetermined intervals.

Additionally, the advantages of using smart drug delivery systems such as improved flexibility, accuracy, and safety of drug delivery are further driving the growth of the segment.

End-User (Hospital, Research Centers)

The hospital segment is set to garner a notable share of 59% shortly on account of rapid advances in medical technology. Hospitals are increasingly looking to upgrade their medical equipment, and microchips are essential components of many of these devices. Moreover, as medical technology continues to advance, microchips will become even more important in enabling hospitals to provide the best possible care to their patients.

Our in-depth analysis of the global market includes the following segments:

           End-User

  • Hospital
  • Research Centers

           Application

  • Drug Administration
  • Home Monitoring

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of microchips in medicine is evaluated at USD 1.35 billion.

The global microchips in medicine market size exceeded USD 1.27 billion in 2025 and is set to expand at a CAGR of over 6.7%, surpassing USD 2.43 billion revenue by 2035.

By 2035, North America is anticipated to secure a 35% share in the Microchips in Medicine Market, impelled by rising healthcare spending.

Key players in the market include Thermo Fisher Scientific Inc., Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos